Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and the Emerging Osteopathic Approach: A Narrative Review.
Larrimore, Christopher, Ramnot, Amanda, Jaghab, Annmarie et al. · The Journal of the American Osteopathic Association · 2019 · DOI
Quick Summary
This article reviews what scientists know about ME/CFS, including its symptoms, how it affects the body, and why it's hard to diagnose. The authors discuss both traditional medical approaches and osteopathic treatment (a type of hands-on therapy that focuses on the body's structure and function) as possible ways to help people with ME/CFS feel better. The review emphasizes that ME/CFS is a real, serious illness that deserves more awareness among doctors and better treatment options.
Why It Matters
This review addresses the critical diagnostic and therapeutic gaps in ME/CFS care by consolidating existing knowledge and proposing an integrative osteopathic perspective. Increased clinical awareness and expanded treatment approaches could improve outcomes for the millions of patients struggling with delayed diagnoses and limited therapeutic options.
Observed Findings
ME/CFS is characterized by profound postexertional malaise, unrefreshing sleep, cognitive dysfunction, immune dysregulation, pain, autonomic dysfunction, and neuroendocrine symptoms.
Clinical diagnosis of ME/CFS is hampered by the absence of diagnostic biomarkers, variation in diagnostic criteria, and limited physician awareness.
Osteopathic approaches may offer complementary benefits by addressing structural and functional body abnormalities.
Current treatment options for ME/CFS remain limited and inadequate for many patients.
Multiple pathophysiological mechanisms contribute to ME/CFS presentation.
Inferred Conclusions
Increased medical community awareness and education about ME/CFS is essential for improving diagnostic accuracy and patient outcomes.
Integrative approaches, including osteopathic medicine, warrant further investigation as adjunctive treatment strategies.
Standardized diagnostic criteria and biomarker development are critical priorities for advancing ME/CFS management.
Multidisciplinary, patient-centered approaches may better address the complex, multisystem nature of ME/CFS.
Remaining Questions
What are the underlying biological mechanisms causing ME/CFS, and can specific biomarkers be identified for diagnosis?
What This Study Does Not Prove
This narrative review does not establish efficacy of osteopathic treatment through randomized controlled trials or quantitative outcome data. It does not prove that osteopathic approaches are superior to or equivalent to standard care, nor does it identify definitive biomarkers or causal mechanisms of ME/CFS pathophysiology.